PH13356A - 4-(3-alkylaminopropoxy)-indolse derivatives - Google Patents

4-(3-alkylaminopropoxy)-indolse derivatives

Info

Publication number
PH13356A
PH13356A PH18788A PH18788A PH13356A PH 13356 A PH13356 A PH 13356A PH 18788 A PH18788 A PH 18788A PH 18788 A PH18788 A PH 18788A PH 13356 A PH13356 A PH 13356A
Authority
PH
Philippines
Prior art keywords
indolse
alkylaminopropoxy
derivatives
indolse derivatives
Prior art date
Application number
PH18788A
Other languages
English (en)
Inventor
F Troxler
F Seemann
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of PH13356A publication Critical patent/PH13356A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH18788A 1975-08-15 1976-08-13 4-(3-alkylaminopropoxy)-indolse derivatives PH13356A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1071475 1975-08-15

Publications (1)

Publication Number Publication Date
PH13356A true PH13356A (en) 1980-03-20

Family

ID=4366041

Family Applications (1)

Application Number Title Priority Date Filing Date
PH18788A PH13356A (en) 1975-08-15 1976-08-13 4-(3-alkylaminopropoxy)-indolse derivatives

Country Status (28)

Country Link
US (1) US4434176A (nl)
JP (2) JPS5223073A (nl)
AT (1) AT363070B (nl)
AU (1) AU505719B2 (nl)
BE (1) BE845197R (nl)
CA (1) CA1080720A (nl)
CY (1) CY1225A (nl)
DE (1) DE2635209C2 (nl)
DK (1) DK152120C (nl)
ES (1) ES450681A1 (nl)
FI (1) FI63751C (nl)
FR (1) FR2320743A2 (nl)
GB (2) GB1575509A (nl)
HK (1) HK35884A (nl)
IE (1) IE43797B1 (nl)
IL (2) IL50263A (nl)
KE (1) KE3404A (nl)
MY (1) MY8500135A (nl)
NL (2) NL176362C (nl)
NO (1) NO762735L (nl)
NZ (1) NZ181764A (nl)
PH (1) PH13356A (nl)
PT (1) PT65477B (nl)
SE (1) SE414633B (nl)
SG (1) SG84883G (nl)
SU (1) SU649313A3 (nl)
YU (1) YU198876A (nl)
ZA (1) ZA764883B (nl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2830211A1 (de) * 1977-07-21 1979-02-01 Sandoz Ag Substituierte indol-derivate, ihre herstellung und verwendung
JPS58106499A (ja) * 1981-12-19 1983-06-24 株式会社東芝 燃料交換装置のクランプ解除機構
HU196125B (en) * 1985-02-05 1988-10-28 Sandoz Ag Process for producing pharmaceutical comprising 3-(aminopropoxy)-indole derivatives combined with diuretic
US5174210A (en) * 1990-04-27 1992-12-29 Heidelberger Druckmaschinen Aktiengesellschaft Preparation of the inking unit of a printing press for a change of printing job
EP0750608A1 (en) * 1994-01-28 1997-01-02 Cal International Limited Pharmaceutical product comprising a salicylate of an esterifiable beta-blocker
CN1812983A (zh) * 2003-05-30 2006-08-02 兰贝克赛实验室有限公司 取代的吡咯衍生物及其作为hmg－co抑制剂的用途
EP1948599A1 (en) * 2005-11-08 2008-07-30 Ranbaxy Laboratories Limited Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
CL2007000667A1 (es) * 2006-03-14 2008-03-14 Ranbaxi Lab Ltd Composicion farmaceutica que comprende al acido 7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]pirrol-1-il]-3,5-dihidroxi-heptanoico o una sal y al menos un agente estabilizante; procedimiento de preparacion, util en e
AU2007274724B2 (en) * 2006-07-14 2012-07-26 Ranbaxy Laboratories Limited Polymorphic forms of an HMG-CoA reductase inhibitor and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3751429A (en) * 1970-03-24 1973-08-07 Sandoz Ltd 4-(3-amino-2-substituted propoxy)indole derivatives
CH532040A (de) * 1970-03-24 1972-12-31 Sandoz Ag Verfahren zur Herstellung neuer Indolderivate
SE375771B (nl) * 1970-09-30 1975-04-28 Sandoz Ag
CH545783A (en) * 1971-01-07 1974-02-15 Novel indole derivs - prepn by reacting 4-(2-hydroxy-3-isopropylaminopropoxy) indoles and acid anhy-drides
CH545784A (en) * 1971-01-07 1974-02-15 Beta blocking and anti-arrhythmic indole derivs - prepd by catalytic de-benzylation of 4-(3-benzyl aminopropoxy) indoles

Also Published As

Publication number Publication date
YU198876A (en) 1982-05-31
JPS5223073A (en) 1977-02-21
NL930134I1 (nl) 1993-11-01
IL50263A0 (en) 1976-10-31
IE43797L (en) 1977-02-15
AT363070B (de) 1981-07-10
NL176362C (nl) 1985-04-01
NL176362B (nl) 1984-11-01
ATA602576A (de) 1980-12-15
IE43797B1 (en) 1981-06-03
FR2320743A2 (fr) 1977-03-11
PT65477A (fr) 1976-09-01
DE2635209C2 (de) 1983-01-27
ES450681A1 (es) 1977-11-16
HK35884A (en) 1984-05-04
DE2635209A1 (de) 1977-02-24
AU505719B2 (en) 1979-11-29
JPS568834B2 (nl) 1981-02-25
NZ181764A (en) 1978-06-20
GB1575510A (en) 1980-09-24
SE7608865L (sv) 1977-02-16
US4434176A (en) 1984-02-28
GB1575509A (en) 1980-09-24
ZA764883B (en) 1978-03-29
FI63751B (fi) 1983-04-29
FR2320743B2 (nl) 1978-11-17
KE3404A (en) 1985-02-01
SE414633B (sv) 1980-08-11
IL58163A0 (en) 1979-12-30
MY8500135A (en) 1985-12-31
CY1225A (en) 1984-04-06
NO762735L (nl) 1977-02-16
FI762258A (nl) 1977-02-16
FI63751C (fi) 1983-08-10
BE845197R (fr) 1977-02-14
DK152120B (da) 1988-02-01
SU649313A3 (ru) 1979-02-25
IL50263A (en) 1980-06-30
NL930134I2 (nl) 1996-11-01
NL7608902A (nl) 1977-02-17
AU1684176A (en) 1978-02-16
CA1080720A (en) 1980-07-01
PT65477B (fr) 1978-05-10
DK357576A (da) 1977-02-16
SG84883G (en) 1985-01-11
DK152120C (da) 1988-06-20
JPS5649318A (en) 1981-05-02

Similar Documents

Publication Publication Date Title
HK23979A (en) Piperidyl-triazine derivatives
ZA766381B (en) New piperidine derivatives
PH12533A (en) New benzhydrylsulphinyl derivatives
GB1550160A (en) 4-hydroxypyrrolidin-2-one derivatives
IL48209A0 (en) Amidinourea derivatives
IL49706A0 (en) Novel anhydro-vinca derivatives
JPS5217472A (en) Substituted nnalkylimidazole derivatives
AU1597876A (en) Ortho-aminobutyrophenone derivatives
PH13356A (en) 4-(3-alkylaminopropoxy)-indolse derivatives
GB1540845A (en) 6-oxo-pyrimidine derivatives
IL59758A0 (en) -amino- , -bis-carobxy-alkane derivatives
AU1074176A (en) Oxadiazolinone derivatives
HK25682A (en) Cis-bicyclooctyl-alkyl-amine derivatives
IE44308L (en) Androsten-17-one derivatives
JPS5212163A (en) Novel cerotonine derivatives
GB1486104A (en) Phthalimidopiperidine derivatives
GB1554720A (en) Pyridthione derivatives
IL49102A0 (en) Triazolobenzocycloalkylthiadiazine derivatives
GB1551442A (en) 11-methylene-6-piperazinyl-morphanthridine derivatives
GB1545577A (en) N-alkyl-3-phenylisoxazole-4-carboxamide derivatives
JPS5268183A (en) Substituted pyrandione derivatives
GB1520011A (en) Benodioxole derivatives
JPS525749A (en) Novel bezophenone derivatives
GB1520682A (en) Monochloro-striazine derivatives
IL49072A0 (en) Triazolocycloalkylthiadiazine derivatives